Anika Therapeutics Inc
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.83 | 2.93 | 2.76 | 2.07 | 2.62 | -0.09 | 1.83 | 1.96 | 1.93 | 2.09 | 2.19 | 2.43 | 8.98 | |
| 1.13 | 1.14 | 1.08 | 0.69 | 2.53 | -1.62 | 0.80 | 0.96 | 0.85 | 0.78 | 0.78 | 0.85 | 3.40 | |
| 1.70 | 1.80 | 1.68 | 1.38 | 0.10 | 1.53 | 1.03 | 1.00 | 1.08 | 1.31 | 1.40 | 1.58 | 5.58 | |
| 0.53 | 0.52 | 0.56 | 0.45 | 0.49 | 0.19 | 0.42 | 0.44 | 0.48 | 0.44 | 0.50 | 0.55 | 2.04 | |
| 1.70 | 1.39 | 1.46 | 1.33 | 1.29 | 0.33 | 0.90 | 0.85 | 0.82 | 0.82 | 1.31 | 0.82 | 3.92 | |
| 2.23 | 6.15 | 2.02 | 1.50 | 1.99 | -0.36 | 1.33 | 1.29 | 1.31 | 1.26 | 1.81 | 1.36 | 5.97 | |
| -0.52 | -4.35 | -0.34 | -0.12 | -1.90 | 1.89 | -0.30 | -0.29 | -0.22 | 0.04 | -0.41 | 0.22 | -0.38 | |
| – | 0.08 | 0.04 | – | – | – | 0.03 | 0.04 | 0.08 | 0.01 | 0.05 | – | – | |
| -0.48 | -4.32 | -0.30 | -0.08 | -1.87 | 1.94 | -0.27 | -0.28 | -0.16 | 0.05 | -0.36 | 0.25 | -0.22 | |
| -0.03 | -0.01 | 0.00 | 0.09 | 0.16 | 0.19 | 0.01 | 0.05 | 0.07 | -0.07 | 0.02 | 0.01 | 0.02 | |
| -0.45 | -4.30 | -0.31 | -0.01 | -2.03 | -1.49 | -0.34 | -0.28 | -0.16 | 0.02 | -0.37 | 0.25 | -0.28 | |
| -0.24 | 0.14 | -0.13 | 0.06 | -1.72 | 1.80 | -0.16 | -0.17 | -0.06 | 0.14 | -0.25 | 0.36 | 0.20 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.